Iran’s Medicine Crisis: Soaring Prices and Shortages Put Patients’ Lives at Risk
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
The Food and Drug Administration announced: The Indian side refused to send pharmaceutical shipments on Iranian planes, making the supply process more difficult. The Islamic Republic newspaper in its "Forward" column...
The Iranian Minister of Health acknowledged the scarcity of at least 32 essential medicines.
The organization that regulates Iran's medicines today admitted that there is a shortage of psychiatric medicines in the country, due to the conflict with the United States, which makes it difficult to import from India, one of the world's leading suppliers of these drugs.
Supply difficulties affect several psychiatric medicines, especially tricyclic antidepressants, a group of medicines used primarily to treat depression.
A spokesperson for the Food and Drug Administration said: "The Indian side refused to send pharmaceutical shipments on Iranian planes, making the supply process more difficult."
The suspension of direct flights from India to Iran and the Indian side's refusal to send shipments on Iranian planes have hampered the process of importing antidepressant drugs.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
